KETAMINE RENAUDIN 50 mg/ml, solution injectable, SODIUM CHLORIDE
APHP240938
Phase 3 small_molecule active
Quick answer
KETAMINE RENAUDIN 50 mg/ml, solution injectable, SODIUM CHLORIDE for Adult patients admitted to the ICU and receiving unplanned invasive mechanical ventilation is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult patients admitted to the ICU and receiving unplanned invasive mechanical ventilation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active